IL2 and glioblastoma: Based on the results obtained from our in vitro experiments, we evaluated the antitumor effects of ex vivo-expanded and HSP70/IL-2-treated NK cells in our GBM rat models and compared two different routes of administration of NK cells (systemic versus intracranial).